Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

U.S. consumers pay higher prices for weight loss drugs than any other ... after using the medication. Former FDA director of investigations in the Chicago area, Ricki Chase, an expert in tracking ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

“The products are not interchangeable and should ... Semaglutide compounders could be next: Novo Nordisk has asked the FDA to ...

Magnesium is an essential mineral with many benefits, such as supporting heart health, reducing inflammation, and maintaining ...

All of them said they are still seeing intense demand for weight-loss medicines ... with coverage or actually getting the product may push some towards compounded product," said Seigerman. The FDA did ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

In the quest for weight loss solutions, a multitude of products flood the market, each promising remarkable results with ...